Hutchmed, controlled by billionaire Li Ka-shing, is set to sell a $608 million stake in its health unit to enhance capital and focus on core operations.
Adani Group's $2 billion stake sale in Adani Wilmar leads to a significant drop in shares, as the conglomerate focuses on bolstering its infrastructure business.